Table 1.
Antigen | Dielmo | Ndiop | Urban SM | |||
---|---|---|---|---|---|---|
IgG level | Prevc (%) | IgG levels | Prev (%) | IgG levels | Prev (%) | |
MSP4-p20a | 1103 | 64 | 2684 | 84 | 1315 | 69 |
[Range] | [28–10,580] | [42–13,160] | [23–6381] | |||
PfCSPa | 262 | 52 | 536 | 57 | 187 | 47 |
[Range] | [22–985] | [22–4969] | [18–1061] | |||
PfAMA1a | 282 | 52 | 402 | 49 | 456 | 58 |
[Range] | [12–2352] | [43–3065] | [46–8930] | |||
PmCSPa | 691 | 56 | 537 | 62 | 79 | 19 |
[Range] | [28–7365] | [29–9278] | [23–991] | |||
MSP4-p20b | 4.5 | 56 | 5.9 | 70 | 6.0 | 75 |
[Range] | [1–14.7] | [1–15.3] | [1–12.9] | |||
Schizont Agb | 3.5 | 64 | 3.1 | 76 | 2.2 | 36 |
[Range] | [1–9.3] | [1–6.0] | [1–7.4] |
a Levels and prevalence of Ab responses measured by MBA (expressed in MFI)
b Levels and prevalence of Ab responses measured by ELISA (expressed in OD ratio)
c Prev prevalence of responders